Unknown

Dataset Information

0

Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodents.


ABSTRACT: A novel phenyl acetamide series of short-acting T-type calcium channel antagonists has been identified and evaluated using in vitro and in vivo assays. Heterocycle substitutions of the 4-position of the phenyl acetamides afforded potent and selective antagonists that exhibited desired short plasma half-lives across preclinical species. Lead compound TTA-A8 emerged as a compound with excellent in vivo efficacy as indicated by its significant modulation of rat sleep architecture in an EEG telemetry model, favorable pharmacokinetic properties, and excellent preclinical safety. TTA-A8 recently progressed into human clinical trials, and in line with our predictions, preliminary studies (n = 12) with a 20 mg oral dose afforded a high C max of 1.82 ± 0.274 ?M with an apparent terminal half-life of 3.0 ± 1.1 h.

SUBMITTER: Yang ZQ 

PROVIDER: S-EPMC4007914 | biostudies-literature | 2010 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications


A novel phenyl acetamide series of short-acting T-type calcium channel antagonists has been identified and evaluated using in vitro and in vivo assays. Heterocycle substitutions of the 4-position of the phenyl acetamides afforded potent and selective antagonists that exhibited desired short plasma half-lives across preclinical species. Lead compound TTA-A8 emerged as a compound with excellent in vivo efficacy as indicated by its significant modulation of rat sleep architecture in an EEG telemetr  ...[more]

Similar Datasets

| S-EPMC4007832 | biostudies-other
2020-02-21 | GSE122763 | GEO
| S-EPMC2799853 | biostudies-literature
| S-EPMC2841875 | biostudies-literature
| S-EPMC4543527 | biostudies-literature
2020-02-21 | GSE122402 | GEO
2020-02-21 | GSE122399 | GEO
| S-EPMC4007971 | biostudies-literature
| S-EPMC3168524 | biostudies-literature
| S-EPMC5366925 | biostudies-literature